- Home
- BRTX vs ECDA Comparison
BRTX vs ECDA Comparison
Compare BRTX & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- ECDA
- Stock Information
- Founded
- BRTX 1997
- ECDA 2013
- Country
- BRTX United States
- ECDA United States
- Employees
- BRTX 11
- ECDA N/A
- Industry
- BRTX Managed Health Care
- ECDA Auto Manufacturing
- Sector
- BRTX Health Care
- ECDA Consumer Discretionary
- Exchange
- BRTX Nasdaq
- ECDA Nasdaq
- Market Cap
- BRTX 13.7M
- ECDA 11.2M
- IPO Year
- BRTX N/A
- ECDA N/A
- Fundamental
- Price
- BRTX $1.67
- ECDA $0.36
- Analyst Decision
- BRTX Strong Buy
- ECDA
- Analyst Count
- BRTX 1
- ECDA 0
- Target Price
- BRTX $18.00
- ECDA N/A
- AVG Volume (30 Days)
- BRTX 27.4K
- ECDA 725.8K
- Earning Date
- BRTX 05-14-2025
- ECDA 06-27-2025
- Dividend Yield
- BRTX N/A
- ECDA N/A
- EPS Growth
- BRTX N/A
- ECDA N/A
- EPS
- BRTX N/A
- ECDA N/A
- Revenue
- BRTX $401,000.00
- ECDA $25,165,733.00
- Revenue This Year
- BRTX $446.88
- ECDA $21.59
- Revenue Next Year
- BRTX $39.53
- ECDA N/A
- P/E Ratio
- BRTX N/A
- ECDA N/A
- Revenue Growth
- BRTX 175.03
- ECDA 29.10
- 52 Week Low
- BRTX $1.03
- ECDA $0.29
- 52 Week High
- BRTX $2.55
- ECDA $1.45
- Technical
- Relative Strength Index (RSI)
- BRTX 41.86
- ECDA 42.49
- Support Level
- BRTX $1.66
- ECDA $0.33
- Resistance Level
- BRTX $1.88
- ECDA $0.53
- Average True Range (ATR)
- BRTX 0.08
- ECDA 0.07
- MACD
- BRTX -0.01
- ECDA 0.02
- Stochastic Oscillator
- BRTX 8.33
- ECDA 28.93
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.